ONO PHARMACEUT./ JP3197600004 /
2024-05-02 8:00:16 AM | Chg. +0.300 | Volume | Bid8:20:02 AM | Ask8:20:02 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
12.800EUR | +2.40% | 0 Turnover: 0.000 |
12.800Bid Size: 200 | 14.800Ask Size: 500 | 7.63 bill.EUR | - | - |
Fundamentals
FY 2022 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 230.85 JPY | 42.33% |
EPS Diluted: | - JPY | 42.32% |
Revenues per Share: | 864.25 JPY | 26.36% |
Book Value per Share: | 1,433.77 JPY | 15.49% |
Cash Flow per Share: | 308.47 JPY | 163.59% |
Dividend per Share: | 70.00 JPY | 25.00% |
Total | in mill. | |
Revenues: | 447,187.00 JPY | 23.75% |
Net Income: | 112,721.00 JPY | 39.99% |
Operating Cash Flow: | 159,610.00 JPY | - |
Cash and Cash Equivalents: | 96,135.00 JPY | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 9.99 | 11.97 |
P/S Ratio: | 2.67 | 3.20 |
P/BV ratio: | 1.61 | 1.93 |
P/CF Ratio: | 7.47 | 8.96 |
PEG: | 0.24 | 0.28 |
Earnings Yield: | 10.01% | 8.35% |
Dividend Yield: | 3.04% | 2.53% |
Market Capitalization | ||
Market Capitalization: | 7.63 bill. EUR | 10.15 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | 2.06 mill. EUR | 2.74 mill. EUR |
Shares Outstanding: | 517.43 mill. |
Profitability
Gross Profit Margin: | 75.39% |
EBIT Margin: | 31.75% |
Net Profit Margin: | 25.21% |
Return on Equity: | 15.19% |
Return on Assets: | 12.77% |
Financial Strength
Liquidity I / Cash Ratio: | 78.20% |
Liquidity II / Quick Ratio: | 171.26% |
Liquidity III / Current Ratio: | 280.73% |
Debt / Equity Ratio: | 18.95% |
Dynam. Debt / Equity Ratio: | 88.07% |
Efficiency
Employees: | 3,700 |
Personal Expenses / Employee: | - JPY |
Revenues / Employee: | 120,861,351.35 JPY |
Net Income / Employee: | 30,465,135.14 JPY |
Total Assets / Employee: | 238,496,486.49 JPY |
* Fiscal Year End: | 2023-03-31 |
Accounting Standard: | IFRS |
Currency: | JPY |